Adoptive cellular therapySZNOL, M; URBA, W. J.Cancer chemotherapy and biological response modifiers annual. 1992, Vol 13, pp 191-204, issn 0921-4410Article

Adoptive cellular therapySZNOL, M; URBA, W. J.Cancer chemotherapy and biological response modifiers annual. 1991, Vol 12, pp 213-230, issn 0921-4410, 18 p.Article

Medical progress : Hodgkin's diseaseURBA, W. J; LONGO, D. L.The New England journal of medicine. 1992, Vol 326, Num 10, pp 678-687, issn 0028-4793Article

Isolation of genes overexpressed in freshly isolated breast cancer specimensKURT, R. A; URBA, W. J; SCHOOF, D. D et al.Breast cancer research and treatment. 2000, Vol 59, Num 1, pp 41-48, issn 0167-6806Article

Immunological monitoring and clinical trials of biological response modifiersKOPP, W. C; HOLMLUND, J. T; URBA, W. J et al.Cancer chemotherapy and biological response modifiers annual. 1994, Vol 15, pp 226-286, issn 0921-4410Article

Immunological monitoring and clinical trials of biological response modifiersBASELER, M. W; KOPP, W. C; URBA, W. J et al.Cancer chemotherapy and biological response modifiers annual. 1993, Vol 14, pp 249-283, issn 0921-4410Article

Immunological and molecular analysis of the sentinel lymph node: A potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine developmentMEIJER, S. L; DOLS, A; DORAN, T et al.Journal of clinical pharmacology. 2001, Vol JUL, pp 81S-94S, issn 0091-2700, SUPArticle

Endocrine effects of IL-1α and β administered in a phase I trial to patients with advanced cancerCURTI, B. D; URBA, W. J; SMITH, J. W et al.Journal of immunotherapy with emphasis on tumor immunology. 1996, Vol 19, Num 2, pp 142-148, issn 1067-5582Article

Phase II trial of interleukin 1α and indomethacin in treatment of metastatic melanomaJANIK, J. E; MILLER, L. L; CONLON, K. C et al.Journal of the National Cancer Institute. 1996, Vol 88, Num 1, pp 44-50, issn 0027-8874, 6 p.Article

Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients : changes during treatmentCURTI, B. D; URBA, W. J; ALVORD, W. G et al.Cancer research (Baltimore). 1993, Vol 53, Num 10, pp 2204-2207, issn 0008-5472Article

Immunoregulation in cancer-bearing hosts : down-regulation of gene expressiuon and cytotoxic function in CD8⁺ T cellsLOEFFLER, C. M; SMIYTH, M. J; OCHOA, A. C et al.The Journal of immunology (1950). 1992, Vol 149, Num 3, pp 949-956, issn 0022-1767Article

Prolonged, continous treatment of hairy cell leukemia patients with recombinant interferon-α2aSMITH, J. W; URBA, W. J; STEIS, R. G et al.Blood. 1991, Vol 78, Num 7, pp 1664-1671, issn 0006-4971Article

Erythrocytosis in hairy cell leukaemia following therapy with interferon alphaSTEIS, R. G; VANDERMOLEN, L. A; LAWRENCE, J et al.British journal of haematology. 1990, Vol 75, Num 1, pp 133-135, issn 0007-1048, 3 p.Article

Appearance of neuropeptides in ascitic fluid after peritoneal therapy with interleukin-2 and lymphokine-activated killer cells for intraabdominal malignancySCHIOGOLEV, S. A; GOETZL, E. J; URBA, W. J et al.Journal of clinical immunology. 1989, Vol 9, Num 2, pp 169-173, issn 0271-9142Article

Synergistic antiproliferative effects of glucocorticoids and interferon-α on some lymphoid cell linesELLIOTT, K. R. F; PRINCLER, G. L; URBA, W. J et al.Journal of cellular physiology. 1988, Vol 134, Num 1, pp 85-92, issn 0021-9541Article

Retrospective analysis of stage I and II indolent lymphomas at the National Cancer InstituteLAWRENCE, T. S; URBA, W. J; STEINBERG, S. M et al.International journal of radiation oncology, biology, physics. 1988, Vol 14, Num 3, pp 417-424, issn 0360-3016Article

One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer : Results of a multicentre, phase II trialHAINSWORTH, J. D; URBA, W. J; HON, J. K et al.European journal of cancer (1990). 1998, Vol 34, Num 5, pp 654-658, issn 0959-8049Article

Immunomodulatory effects of interferon-γ in patients with metastatic malignant melanomaKOPP, W. C; SMITH, J. W; EWEL, C. H et al.Journal of immunotherapy. 1993, Vol 13, Num 3, pp 181-190, issn 1053-8550Article

Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2CURTI, B. D; LONGO, D. L; JANIK, J. E et al.Journal of clinical oncology. 1993, Vol 11, Num 4, pp 652-660, issn 0732-183XArticle

Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequences with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinomaSZNOL, M; CLARK, J. W; CREEKMORE, S. P et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 12, pp 929-937, issn 0027-8874Article

Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer : clinical and immunological effectsEWEL, C. H; URBA, W. J; BEVERIDGE, J. M et al.Cancer research (Baltimore). 1992, Vol 52, Num 11, pp 3005-3010, issn 0008-5472Article

Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4⁺ peripheral blood lymphocytesCONLON, K. C; OCHOA, A. C; KOPP, W. C et al.The Journal of immunology (1950). 1992, Vol 149, Num 10, pp 3278-3289, issn 0022-1767Article

Diffuse osteosclerosis in hairy cell leukemiaVANDERMOLEN, L. A; URBA, W. J; LONGO, D. L et al.Blood. 1989, Vol 74, Num 6, pp 2066-2069, issn 0006-4971Article

Immunomodulation of natural killer cell activity by flavone acetic acid: occurrence via induction of interferon α/βHORNUNG, R. L; YOUNG, H. A; URBA, W. J et al.Journal of the National Cancer Institute. 1988, Vol 80, Num 15, pp 1226-1231, issn 0027-8874Article

Tumors of the heart and pericardiumWILDING, G; GREEN, H. L; LONGO, D. L et al.Cancer treatment reviews. 1988, Vol 15, Num 3, pp 165-181, issn 0305-7372Article